Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome. [electronic resource]
Producer: 20180124Description: 180-7 p. digitalISSN:- 2150-1319
- Adult
- Atorvastatin -- therapeutic use
- Cost-Benefit Analysis
- Diabetes Mellitus -- epidemiology
- Dyslipidemias -- drug therapy
- Female
- Humans
- Hypolipidemic Agents -- administration & dosage
- Lipids -- blood
- Male
- Metabolic Syndrome -- epidemiology
- Middle Aged
- Pravastatin -- therapeutic use
- Rosuvastatin Calcium -- therapeutic use
- Simvastatin -- therapeutic use
- Socioeconomic Factors
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.